Singapore: Researchers at Institute of Bioengineering and Nanotechnology (IBN), Singapore have developed a genetic test ...
Singapore: Leo Pharma launched Psoriasis Coach All-Round Education (PsorCARE) program in Singapore on January 26, 2013....
Singapore: Scientists at A*Star's Genome Institute of Singapore (GIS) and US-based Stanford University's School of Medic...
Singapore: Singapore has been witnessing strong performance. Here are a few developments in the country that are proof...
There have been recent changes to the US patent laws that have brought the US laws closer to those of the rest-of-the-wo...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore: The liver is an important target organ for drug testing because all drugs pass through it for detoxification...
Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...
Singapore: Singapore based biotechnology firm, Austrianova, has received Board of Investment (BOI) status for its Thai s...
Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of S$7.4 billion in 2011, according to t...
Singapore: Scientists at A*STAR's Genome Institute of Singapore (GIS) have successfully developed a method to map the ep...
Singapore: Scientists from Singapore have identified FAIM, a molecule that typically prevents cell death, as a potential...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Korean Health Industry Development Insti...
The rising demand for cost containment in healthcare and the need to improve quality of services are driving the growth ...
Singapore: Telecommunication companies in Asia-Pacific are increasingly exploring vertical markets like healthcare to op...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancer...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
